☆ 4.6 Article

Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

BMC CANCER (2023)

Related references

Note: Only part of the references are listed.

Review Oncology

State of the Art MR Imaging for Lung Cancer TNM Stage Evaluation

Yoshiharu Ohno et al.

Summary: Technical advancements in magnetic resonance (MR) imaging have made it possible to use it as a diagnostic tool for thoracic malignancies, providing both morphological and functional information. According to the recommendation from the Fleischner Society in 2020, MR imaging can be used for the diagnosis of lung diseases. This review focuses on the application of MR imaging in lung cancer, pulmonary nodules, and masses.

CANCERS (2023)

Add to Collection

Review Oncology

Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives

Alessandro Ottaiano et al.

Summary: Oligometastatic disease is a condition in which cancer spreads to only a few distant sites, and it is associated with a more favorable prognosis compared to polymetastatic disease. Recent studies have identified specific molecular and genetic features that underlie the oligometastatic phenotype, suggesting the potential for personalized therapies. This scoping review highlights new clinical, biological, and methodological challenges in understanding and treating oligometastatic disease.

CANCERS (2023)

Add to Collection

Article Oncology

Initial tumour burden and hidden oligometastatic disease in phase 3 clinical trials

Alessandro Ottaiano et al.

LANCET ONCOLOGY (2022)

Add to Collection

Article Oncology

Colorectal Cancer Preoperative Evaluation and Staging

Najjia N. Mahmoud

Summary: Colorectal tumor staging has undergone some changes over time, but not significantly. In the past 10 years, advancements in our understanding of tumor genetics and the use of MRI technology for rectal cancer staging have altered the way we assess colon and rectal cancers. Currently, CT scanning, a thorough history and physical examination, and colonoscopic assessment are still the mainstays of staging. Successful staging of colorectal cancer requires coordination and cooperation between surgery, gastroenterology, medical oncology, pathology, and radiology.

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2022)

Add to Collection

Article Immunology

Characterization of KRAS Mutational Regression in Oligometastatic Patients

Alessandro Ottaiano et al.

Summary: This study found that the oligometastatic status is a significant and independent prognostic factor in colorectal cancer patients. Some patients exhibited genetic regression of KRAS and showed differential cytotoxicity against colon cancer cells carrying different KRAS mutations.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Oncology

Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review

Mariachiara Santorsola et al.

Summary: The study highlighted the importance of better assessment of initial tumour burden in clinical trials, as well as the need for more attention to low-burden metastatic disease as a stratification factor. Only a small percentage of studies included low-burden disease as a stratification for randomisation, and significant imbalances between arms in patients with low-burden disease were revealed in two studies.

CANCERS (2022)

Add to Collection

Article Oncology

KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer

Alessandro Ottaiano et al.

Summary: Our study demonstrates that the evolutionary trajectories of KRAS play a significant clinical prognostic role in CRC patients and can help differentiate between poly-metastatic aggressive and oligo-metastatic indolent CRC.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease?

Alessandro Ottaiano et al.

Summary: Colorectal cancer originates from multiple genetic alterations, with some genes extensively studied. Approximately 10% of metastatic CRC patients present with indolent oligo-metastatic disease, highlighting the importance of studying the genetic dynamics between oligo- and poly-metastatic diseases for therapeutic strategies.

TRANSLATIONAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Survey of 1,378 Patients

Yuzuru Niibe et al.

ANTICANCER RESEARCH (2020)

Add to Collection

Review Oncology

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

Matthias Guckenberger et al.

LANCET ONCOLOGY (2020)

Add to Collection

Article Cell Biology

Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer

Alessandro Ottaiano et al.

CELL DEATH & DISEASE (2020)

Add to Collection

Article Oncology

Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document

Yolande Lievens et al.

RADIOTHERAPY AND ONCOLOGY (2020)

Add to Collection

Review Oncology

Oligometastases: history and future vision of breast cancer

Yuzuru Niibe et al.

TRANSLATIONAL CANCER RESEARCH (2020)

Add to Collection

Article Oncology

Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer

Alessandro Ottaiano et al.

CANCERS (2020)

Add to Collection

Review Oncology

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy

Daniela Bruni et al.

NATURE REVIEWS CANCER (2020)

Add to Collection

Review Oncology

The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios

Nicola Normanno et al.

CANCER TREATMENT REVIEWS (2018)

Add to Collection

Letter Oncology

Oligo-recurrence and Sync-oligometastases In Response

Yuzuru Niibe et al.

JOURNAL OF THORACIC ONCOLOGY (2018)

Add to Collection

Article Oncology

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial

N. Normanno et al.

ANNALS OF ONCOLOGY (2015)

Add to Collection

Review Oncology

Next-generation sequencing in the clinic: Promises and challenges

Jiekun Xuan et al.

CANCER LETTERS (2013)

Add to Collection

Review Respiratory System

Novel Insights of Oligometastases and Oligo-Recurrence and Review of the Literature

Yuzuru Niibe et al.

PULMONARY MEDICINE (2012)

Add to Collection

Review Oncology

Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy

Yuzuru Niibe et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)

Add to Collection

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.